tiprankstipranks
Trending News
More News >
Viking Therapeutics (DE:1VT)
FRANKFURT:1VT
Germany Market

Viking Therapeutics (1VT) Balance Sheet

Compare
71 Followers

Viking Therapeutics Balance Sheet

Viking Therapeutics's total assets for Q3 2025 were $739.41M, a decrease of -10.68% from the previous quarter. DE:1VT total liabilities were $26.39M for the fiscal quarter, a -18.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 908.32M$ 368.49M$ 168.53M$ 210.66M$ 256.50M
Total Liabilities
$ 28.04M$ 20.07M$ 23.21M$ 8.78M$ 12.16M
Total Equity Gross Minority
$ 880.28M$ 348.42M$ 145.32M$ 201.88M$ 244.34M
Other Metrics
Currency in USD

Viking Therapeutics Debt to Assets